Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia May 2024 24(5):e181-e190 - Subject
- Language
- ISSN
- 2152-2650